The European Commission has today made two legislative proposals to amend the founding Regulations of the European Medicines Agency (EMA) and the European Banking Authority (EBA).
This follows last week’s agreement in the margins of the General Affairs Council (Article 50 format) to move the EMA and the EBA from London to Amsterdam and Paris, respectively.
The Commission is acting swiftly in order to provide legal certainty and clarity, ensuring that both Agencies can continue to function smoothly and without disruption beyond March 2019. Under the ordinary legislative procedure, the co-legislators (the European Parliament and the Council) are expected to give priority to the handling of these legislative proposals. These proposals are strictly limited to confirming the new seats of the Agencies in the two founding Regulations.
The relocation of these two Agencies is a direct consequence of the United Kingdom’s decision to leave the European Union, as notified to the European Council on 29 March 2017. The decision to relocate both Agencies was for the governments of the 27 Member States to take. It does not form part of the Brexit negotiations.
CREDIT: © EUROPEAN UNION, 2017